[Drug metabolism: chronic alcoholism and cirrhosis].
The growing interest for research addressing the interactions between drug and alcohol metabolisms is not unrelated to the increasing prevalence of alcoholism and associated drug additions. Most physicians are now aware of the increased therapeutic risk in alcoholics, but the intimate mechanism of this interaction is usually unknown. On the whole, while many studies address the problems related to drug-alcohol interactions, those on the interactions between chronic alcoholism and cirrhosis are scarce or imprecise.
D000437:Alcoholism / Q000378:metabolism*; D000900:Anti-Bacterial Agents / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D000925:Anticoagulants / Q000378:metabolism; D000995:Antitubercular Agents / Q000378:metabolism; D002317:Cardiovascular Agents / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism; D008104:Liver Cirrhosis, Alcoholic / Q000378:metabolism*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011619:Psychotropic Drugs / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D000995:Antitubercular Agents; D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs
Métabolisme des médicaments: alcoolisme chronique et cirrhose.